Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Industry

27 Jul 2023

Rexis Biotech: Improving Functional Ingredients With Innovative Technology

Rexis Biotech is using new technology to change how we produce and consume consumer ingredients....

By Microdose

Law & Politics

13 Jul 2023

After MDMA Legalization: The Path to Legal Psychedelics

FDA approval of MDMA will be a milestone that will accelerate the path toward legal psychedelics. What other work needs to be done?...

By Microdose
mushroom music

Culture

11 Jul 2023

Microdose Music and Paul Nolan to Lauch New Psychedelic Album & Music Summit

Paul Nolan's Boundary-Transcending Album 'Dissolve' Paves the Way for a Music and Consciousness Summit by Microdose Music...

By Microdose

Law & Politics

6 Jul 2023

Pay-For-Success Contracts: An Open Source Alternative to Psychedelic Patents

The role of patents in the ongoing psychedelic renaissance incites robust debate. In this piece, we describe an alternative pay-for-success (PFS) contract system that can be used instead of patents...

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Culture

30 Jun 2023

Psychedelic Decriminalization: How Drug Policies Impact Public Health

We explore the case for psychedelic decriminalization and how drug policies impact public health....

By Microdose

Law & Politics

29 Jun 2023

The Road to Legal Psychedelics: Is Cannabis a Good Comparison?

We compare the journeys of the cannabis and psychedelic industries in their pursuit of legalization....

By Microdose

Culture

28 Jun 2023

Legal Psychedelics: Culture and Local Politics Are Leading the Way

Local initiatives and cultural changes are playing a pivotal role in spearheading decriminalization and legalization efforts and the future of legal psychedelics....

By Microdose

Health & Wellness, Law & Politics

27 Jun 2023

Is Ketamine Legal? A Look at Legal Psychedelics

With clinical trials moving MDMA toward FDA approval, celebrities continuing to share their psychedelic experiences, and politicians supporting new research — many people are wondering if psychedelics are actually legal....

By Microdose

Law & Politics

22 Jun 2023

MDMA Legalization: The Road to Legal MDMA and FDA Approval of Psychedelics

With FDA approval of MDMA therapy estimated to come within the next year, we take a closer look at the road to MDMA legalization....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.